Merck Posts Global Sales of $11B in Third Quarter

By THE ASSOCIATED PRESS
NYT
A big jump in U.S. medicine sales, particularly for its key cancer drug, helped Merck & Co. swing to a $2 billion profit from a small loss a year earlier due to large one-time charges.
Published date: October 25, 2018 at 02:17PM
AP
New York Times article